Web Version

Webinar Invitation

Overcoming the barriers to antibody discovery with
on-cell mAb screening and surface plasmon resonance

Thursday, 5th May 2022

4:00 PM Central European Summer Time | REGISTER

All registrants will receive a link to the recorded version.


Viruses are known to be highly susceptible to mutations, often resulting in the emergence of variant strains. While some will disappear, others will persist and challenge our global healthcare system, just as we saw with the COVID-19 pandemic.

Join us in a conversation with Scott Dessain (OCMS) and Marko Jovic (Nicoya), who will discuss the application of novel mAb screening technology and surface plasmon resonance (SPR) for rapid discovery and characterization of variant-specific antibodies, and will delve into the future of immunodiagnostics.

  • Challenges of emerging viral variants
  • New strategies for viral detection
  • Accelerating antibody discovery with rapid screening and characterization
  • Emerging technologies for mAb engineering

Nicoya's Benchtop SPR Instruments

Scott Dessain, MD, PhD
Founder, CSO at OCMS


Marko Jovic, PhD
Training & Development
Manager at Nicoya

BioCat GmbH

Im Neuenheimer Feld 584
D-69120 Heidelberg
Tel:  +49 (0) 6221 7141516
Fax: +49 (0) 6221 7141529
Email: info@biocat.com
Web: http://www.biocat.com